Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
MiNK Therapeutics, Inc. (INKT) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.24M |
|
-- |
|
-- |
|
$4.05M |
|
$-4.05M |
|
$-0.19M |
|
$-4.24M |
|
$-4.24M |
|
$-4.24M |
|
$-4.24M |
|
$-4.24M |
|
$-4.24M |
|
$-4.05M |
|
$-4.00M |
|
3.98M |
|
3.98M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$2.01M |
|
$0.47M |
|
$0.47M |
|
$2.48M |
|
$13.16M |
|
-- |
|
$14.51M |
|
$27.67M |
|
$-25.19M |
|
$-25.19M |
|
$-25.19M |
|
3.99M |
|
| Cash Flow Statement Financials | |
$-2.91M |
|
-- |
|
$0.00M |
|
$4.58M |
|
$1.68M |
|
$-2.90M |
|
$1.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-0.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
16.82% |
|
16.82% |
|
-170.57% |
|
16.82% |
|
$-6.31 |
|
$-0.73 |
|
$-0.73 |
|